TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
QGEN

Qiagen NV

Healthcare · Diagnostics & Research

44.60$ +1.9% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Income Statement

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Income Statement QGEN
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
5.78 5.61 5.81 6.08 6.43 6.94 8.23 10.00 9.59 9.04 9.05 10.05
2.06 1.99 2.14 2.12 2.15 2.37 2.81 3.56 3.39 3.36 4.63 3.84
3.72 3.62 3.67 3.96 4.29 4.57 5.43 6.45 6.20 5.67 4.43 6.21
0.70 0.64 0.77 0.66 0.69 0.72 0.66 0.84 0.85 0.91 0.89 0.90
0.54 0.45 0.56 0.86 0.60 0.51 0.49 0.57 0.58 0.55 0.52 0.60
3.02 2.83 3.24 3.30 3.15 4.69 3.73 3.65 3.82 3.79 3.98 3.71
0.70 0.79 0.43 0.66 1.14 -0.12 1.70 2.80 2.38 1.88 0.45 2.50
0.17 0.16 0.17 0.21 0.29 0.34 0.31 0.24 0.26 0.25 0.20 0.16
0.51 0.60 0.25 0.49 0.97 -0.35 1.93 2.78 2.30 1.98 0.55 2.36
0.01 0.03 -0.10 0.32 0.15 -0.17 0.35 0.50 0.40 0.41 0.17 0.31
0.50 0.57 0.35 0.17 0.82 -0.19 1.58 2.28 1.90 1.57 0.38 2.04
1.55 1.60 1.34 1.63 2.14 1.04 3.15 3.98 3.49 3.17 1.69 3.45

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?